financetom
Business
financetom
/
Business
/
Taiwan says US has 'high' urgency in speeding up weapons deliveries
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Taiwan says US has 'high' urgency in speeding up weapons deliveries
Mar 24, 2026 8:38 PM

TAIPEI, March 25 (Reuters) - The United States has

"quite a high" sense of urgency in helping Taiwan strengthen its

military capabilities and is working to help speed up delayed

weapons deliveries, the island's Defence Minister Wellington Koo

said on Wednesday.

Taiwan, which faces a rising military threat from China, has

complained of repeated delays to weapons ordered from the United

States, the most important international backer and arms

supplier to the island, which Beijing claims as its territory.

One of the main delays is to a 2019 order for 66 Lockheed

Martin F-16V fighters, equipped with more advanced

avionics, weapons and radar systems to better face down the

Chinese air force, including its stealthy J-20 fighters.

Deliveries of many of the weapons systems ordered have

already begun or arrived, Koo told reporters at parliament.

"As for the portions that have experienced delays, the

United States has already set up a special project team to

accelerate the relevant weapons programmes and help us catch up

to schedule as quickly as possible," he said.

"I have also repeatedly explained that the U.S. sense of

urgency in helping us strengthen our self-defence capabilities

as quickly as possible is in fact quite high."

Deliveries of F-16V fighter jets for Taiwan will begin this

year with production at "full capacity", the ministry said at

the weekend.

Last week, Michael Miller, director of the U.S. Defense

Security Cooperation Agency, said he signed a directive in 2023

to prioritise Taiwan above other buyers, adding that security

cooperation and assistance for Taiwan was a top priority.

The United States is bound by law to provide Taiwan with the

means to defend itself, and arms sales are a constant source of

friction between Washington and Beijing, which has demanded that

they stop.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amrize Insider Bought Shares Worth $250,474, According to a Recent SEC Filing
Amrize Insider Bought Shares Worth $250,474, According to a Recent SEC Filing
Mar 11, 2026
02:17 PM EDT, 03/11/2026 (MT Newswires) -- Ian A Johnston, Chief Financial Officer, on March 10, 2026, executed a purchase for 4,250 shares in Amrize ( AMRZ ) for $250,474. Following the Form 4 filing with the SEC, Johnston has control over a total of 25,110 ordinary shares of the company, with 25,110 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2035989/000203598926000030/xslF345X05/primary_doc.xml Price:...
Ondas Stock Falls Wednesday Despite Strong Revenue, Israel Contract News
Ondas Stock Falls Wednesday Despite Strong Revenue, Israel Contract News
Mar 11, 2026
Ondas Inc ( ONDS ) shares are trading lower Wednesday afternoon, even as investors weigh a string of recent company announcements that highlight strong revenue momentum and expansion in its defense technology business. Here’s what investors need to know. Ondas ( ONDS ) stock is among today’s weakest performers. What’s behind ONDS decline? Ondas Reports Strong Preliminary Revenue, Secures Israel...
Vicor Insider Sold Shares Worth $8,862,569, According to a Recent SEC Filing
Vicor Insider Sold Shares Worth $8,862,569, According to a Recent SEC Filing
Mar 11, 2026
02:23 PM EDT, 03/11/2026 (MT Newswires) -- Patrizio Vinciarelli, 10% Owner, Director, Chairman and CEO, on March 10, 2026, sold 50,000 shares in Vicor ( VICR ) for $8,862,569. Following the Form 4 filing with the SEC, Vinciarelli has control over a total of 9,629,288 common shares of the company, with 9,458,163 shares held directly and 171,125 controlled indirectly. SEC...
Solid Biosciences Reports Interim Phase 1/2 Results in Duchenne Trial
Solid Biosciences Reports Interim Phase 1/2 Results in Duchenne Trial
Mar 11, 2026
02:22 PM EDT, 03/11/2026 (MT Newswires) -- Solid Biosciences ( SLDB ) on Wednesday reported interim results from its phase 1/2 trial of SGT-003, a gene therapy being developed to treat Duchenne muscular dystrophy. So far, 40 participants have received the treatment. The company said the therapy has been generally well tolerated and that interim analyses suggest robust microdystrophin expression,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved